NexImmune, Inc. has reported significant corporate governance changes in a recent Form 8-K filing with the SEC dated June 7, 2024. The company's Board of Directors approved an amendment to the Amended and Restated Bylaws, which now stipulates that a quorum at stockholder meetings will require one-third of the voting power of all shares entitled to vote. This amendment took effect on the same day. Additionally, on June 11, 2024, NexImmune filed a Certificate of Designation for one share of Series A Preferred Stock, which has special voting rights tied to certain company dissolution-related proposals but is not convertible into common stock and does not entitle the holder to dividends. The preferred share will have a significant number of votes equivalent to the outstanding common shares if a Voting Proposal related to the company's dissolution receives more 'for' votes than 'against' or 'abstain' votes. The preferred share may also be redeemed by the company at any time for $0.01, subject to Delaware law and the Board's fiduciary duties.

NexImmune, Inc. has reported significant corporate governance changes in a recent Form 8-K filing with the SEC dated June 7, 2024. The company's Board of Directors approved an amendment to the Amended and Restated Bylaws, which now stipulates that a quorum at stockholder meetings will require one-third of the voting power of all shares entitled to vote. This amendment took effect on the same day. Additionally, on June 11, 2024, NexImmune filed a Certificate of Designation for one share of Series A Preferred Stock, which has special voting rights tied to certain company dissolution-related proposals but is not convertible into common stock and does not entitle the holder to dividends. The preferred share will have a significant number of votes equivalent to the outstanding common shares if a Voting Proposal related to the company's dissolution receives more 'for' votes than 'against' or 'abstain' votes. The preferred share may also be redeemed by the company at any time for $0.01, subject to Delaware law and the Board's fiduciary duties.